Domicile
Reels
Groupes
Pages
Plus
Groupes Pages Evènements Blogs Offres Emplois Courses Forums Film Jeux
Se connecter S’enregistrer
Mode nuit
Why Monoclonal Antibodies Lead the Oncology Biosimilars Market
Monoclonal antibodies have transformed cancer treatment by targeting specific proteins and pathways involved in tumor growth or immune regulation. As the patents of major biologic medicines expire, biosimilar versions are creating new competition in oncology. The Oncology Biosimilars Market is forecast to grow from USD 5.469 billion in 2024 to USD 14.4 billion by 2035. Monoclonal antibodies...
0 Commentaires ·0 Parts ·226 Vue ·0 Aperçu
Connectez-vous pour aimer, partager et commenter!